Replies to post #2578 on GeneThera Inc. (GTHR)

[SAE]

E.T. I don't have time to do any reading, but your post says that the officers can be paid in "common" shares. I believe they were paid in "B" shares. "B" shares can be converted to 10 common shares. When I have time, I want to see what the 10-K's and 10-Q's say about payment in shares.

Common shares are not preferred (A or B) IMO! What do other companies do?



http://ih.advfn.com/p.php?pid=nmona&article=49807357

EMPLOYEES

As of December 31, 2009, we had a total of two full-time employees who devoted substantial effort on our behalf. None of our employees are represented by a collective bargaining unit. We entered into an employment agreement with Antonio Milici, M.D., Ph.D., to serve as our Chief Executive Officer and Chief Scientific Officer through January 7, 2012. In consideration for his services, Dr. Milici will receive a base salary of $144,000 per annual plus bonuses as may be determined by the Board of Directors in its sole discretion. As part of his employment agreement, Dr. Milici is subject to non-disclosure and non-competition obligations and has transferred to the Company all of his interests in any idea, concept, technique, invention or written work. We also entered into an employment agreement with Tannya L. Irizarry to serve as our Chief Administrative Officer through January 7, 2012. Ms. Irizarry’s base salary is $135,000 per annum. The above salaries have been accrued to be paid in common stock shares from the Company. There are no employee issues at this time.